Integra LifeSciences cuts 2026 revenue and EPS outlook after Cincinnati flood
Integra LifeSciences released preliminary third-quarter 2026 results and lowered its full-year 2026 revenue and adjusted EPS guidance after July flooding at its Cincinnati manufacturing facility. The company says the flood reduced third-quarter revenue by about $7 million and will reduce fourth-quarter revenue by $15 million to $20 million, and it expects insurance to offset a substantial portion of the earnings impact.
Key points
- Third-quarter revenue expected at $410 million to $412 million, with adjusted EPS of $0.55 to $0.59; results are unaudited and subject to closing procedures.
- Full-year 2026 revenue outlook lowered to $1.634 billion to $1.654 billion from $1.654 billion to $1.695 billion; adjusted EPS guidance lowered to $2.30 to $2.40 from $2.40 to $2.50.
- Full-year 2026 operating cash flow expected at about $190 million to $200 million, and greater than $85 million in the third quarter.
- Full manufacturing operations at the Cincinnati facility are expected to return during the second quarter of 2027.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 02, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.